http://www.the-infoshop.com/bio.shtml Biotechnology Market Research Reports Global Information, Inc. (C) 2008 Global Information, Inc. 2009-11-20 daily en Regenerative Medicine 2009-11-17 BioInformant http://www.the-infoshop.com/study/biof82927-hesc.html The low number of licensing agreements suggests that many companies find WARF' s licensing fees to be unwieldy, which isn' t surprising given that disclosed fees have ranged from $75,000 to more than $250,000, plus annual payments and royalties. While Invitrogen, Becton Dickinson and Chemicon have disclosed licensing agreements with WARF, many research products companies have to explore less costly alternatives - such as circumventing the claims, conducting research off-shore, potential use of abnormal karyotypes, developing embryonic stem cell products for other species, and pursuing strategic collaborations. This market report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies that want enter the product area. en Genome-based Drug Discovery 2009-11-09 Markets and Markets http://www.the-infoshop.com/study/mama103301-glob-stem-cell.html The healthcare industry has recently witnessed the adoption of many new technologies that increase the efficiency of various medical treatments. Minimally invasive surgery (MIS) is one of the most important developments among all such cutting-edge medical technologies. This report uses the term 'minimally invasive surgery' to include non-invasive surgeries as well. The increasing demand of specialized treatment has propelled the market growth for MIS; and many companies - especially the new entrants from developing nations - are competing to benefit out of the rapid growth of this market. en Genome-based Drug Discovery 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70915-diagnostics.html 1This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, biochips, nanotechnology and proteomic technologies. en Regenerative Medicine 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70916-cell-therapy.html This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice. en Genome-based Drug Discovery 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70918-proteomics.html This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. en 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70922-animal-bio.html This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology. en Personalized Medicine 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70924-medicine.html The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of molecular diagnostics play an important role, particularly those for single nucleotide polymorphism (SNP) genotyping. en Genome-based Drug Discovery 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70930-rnai.html RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy complementary RNA. The report compares RNAi with other antisense approaches using oligonucleotides, aptamers, ribozymes, peptide nucleic acid and locked nucleic acid. en Gene Therapeutics & RNAi 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70931-gene-therapy.html Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of vectors and various techniques are being used to modify the function of genes in vivo without gene transfer. If one adds to this the cell therapy particularly with use of genetically modified cells, the scope of gene therapy becomes much broader. Gene therapy can now combined with antisense techniques such as RNA interference (RNAi), further increasing the therapeutic applications. This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies. This report describes the setbacks of gene therapy and renewed interest in the topic. en 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70933-nanobio.html Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare. The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters. en 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70937-biomarkers.html This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker. en 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70938-cytogenetics.html This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. en 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai70939-therapeutics.html This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their commercial importance. Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections. Expert opinion is given about the current problems and needs in antiviral therapy. SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent. en Genome-based Drug Discovery 2009-11-02 Jain Pharmabiotech http://www.the-infoshop.com/study/jai84243-dna-sequ-tech.html This report briefly reviews development of sequencing technologies, current large and small sequencers as well as companies developing them. Companies developing software for analysis of sequencing data are listed. Selected academic institutes conducting research in sequencing are also listed. en Antibody & Immunity 2009-11-02 Datamonitor http://www.the-infoshop.com/study/dc103027-monoclonal-antibo.html The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also provides an insight into the direction of mAb technology evolution and an analysis of pipeline dynamics. en Molecular Targeted Therapeutics 2009-11-02 France Innovation Scientifique et Transfert (FIST SA) http://www.the-infoshop.com/study/fist103038-cdk-inhibitor.html Regulating cell function by controlling cell pathways is an important strategy in the development of agents for the treatment of cancer and numerous other diseases. Protein kinases are a family of enzymes involved in the regulation of almost all cell processes. Scientists have identified 518 kinases encoded by the human genome. en Biotechnology Equipment 2009-10-30 BioInformatics, LLC http://www.the-infoshop.com/study/bf102383-res-prod-fy2010.html The Market Outlook for Research Products in FY2010 compares and contrasts FY2009 (actual) and FY2010 projected) budgets - in total, and by product category with a special focus on market segment and regional differences. In this report, European and U.S. scientists are asked about planned purchases of both consumables and instrumentation, and from what sources they expect to receive funding, with an emphasis on the ARRA. Significantly, scientists also indicate from which supplier they plan to purchase in each category - and why. Early results indicate that there are clear winners in some of the product categories. special section is devoted to the shift that was identified in our early 2009 budget report - an increase in outsourcing to CRO' s. We asked labs what services have been outsourced in the past two years, what services will be contracted over the next two years, and how much influence labs have over a contractor' s choice of supplier, instruments and consumables when performing work for the lab. We also gathered their thoughts as to when they believe the recession will end for life scientists - in the U.S. and in Europe, and how they feel about what' s in store for 2011. In this report, scientists weigh-in on ways they are cutting costs in the labs, and whether they feel these changes will be permanent, or just temporary measures to weather the economic storm. Plus, in a spirit of collaboration, suppliers have extended promotions and incentives to labs; find out in this report which ones are working. en 2009-10-28 Millennium Research Group http://www.the-infoshop.com/study/mrg102637-asia-orthopedic.html The market for Asia Pacific orthopedic biomaterials will be primarily driven by the region' s aging population that requires greater care and maintenance of their bones and joints. The hyaluronic acid viscosupplementation segment will be favorably affected by both the aging and physically active demographics, as well as rising awareness of the treatment' s benefits among physicians and patients. The market will, however, be limited by price competition and reimbursement challenges. en Regenerative Medicine 2009-10-23 Business Insights http://www.the-infoshop.com/study/rb102487-stem-cell-ind.html An important milestone in the development of stem cell technology occurred in 2007, when researchers induced human cells into a stem cell state using defined genetic factors. These cells are now known as induced pluripotent stem (IPS) cells; they offer an alternative to using embryonic stem cells. This report takes the implications of IPS cells and other developments into account. Some essential technologies are already in place and stem-cell based therapies have already begun to appear in the marketplace. en 2009-10-19 La Merie http://www.the-infoshop.com/study/lmer102247-coagula-factor.html The present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of October 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. en Regenerative Medicine 2009-10-13 BCC Research http://www.the-infoshop.com/study/bc102126-regenerative-medicines.html This report provides a comprehensive overview of the global market for regenerative medicines for bone and joint applications. en 2009-10-13 Decision Resources, Inc. http://www.the-infoshop.com/study/dr102137-clinical-research.html Biomarkers and imaging tools are enabling technologies in today' s clinical research efforts for neurological diseases. Whether to improve upon existing methods for monitoring disease progression or to discover validated measures to detect diseases earlier than before, nearly every neurology trial is relying on biomarkers and/or has an imaging component. en Biomarker 2009-10-12 Technical Insights, Inc. http://www.the-infoshop.com/study/ti102345-advance-biomarker.html This award deliverable provides an exhaustive overview of biomarkers and the current trends in biomarker research.This study covers technologies for biomarker identification; applications of biomarkers in the field of medicine; developments and trends in Biomarkers and the impact of Biomarkers in the medical field. en 2009-10-09 Percepta Associates Inc. http://www.the-infoshop.com/study/pai102407-transfec-life-sc.html The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard Series Two was developed from responses to a 24-question survey completed by over 427 scientists predominantly located in North America and Europe. en 2009-10-01 Global Industry Analysts, Inc. http://www.the-infoshop.com/study/go100755-genealogy-product.html The global outlook series on Genealogy Products and Services provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird' s eye view of the industry; highlights latest market trends, and demand drivers. en 2009-10-01 Global Industry Analysts, Inc. http://www.the-infoshop.com/study/go101186-genetic-engineeri.html The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird' s eye view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry' s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. The report also provides select data on regional markets. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 169 companies active in the market. en 2009-10-01 Business Insights http://www.the-infoshop.com/study/rb103270-biomarkers-biochip.html Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only recently that they have moved towards meeting the requirements of the clinical and regulatory communities with the first DNA microarray test being approved by the US FDA in 2007. en Biotechnology Equipment 2009-09-30 Frost & Sullivan http://www.the-infoshop.com/study/fs100966-eu-biomarker.html This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015. en Biotechnology Equipment 2009-09-19 Frost & Sullivan http://www.the-infoshop.com/study/fs100427-eu-tissue-diagno.html This research service analyses the revenue potential for tissue diagnostics markets in major western European countries. It also gives the overview of the market together with market drivers,restraints and challenges in the whole Europe. en Biotechnology Equipment 2009-09-15 BCC Research http://www.the-infoshop.com/study/bc100145-cell-tissue.html This BCC Research report, Cell and Tissue Analysis Products: The Global Market, provides a detailed analysis of the products and technologies that define the market space and summarizes the composition and dynamics of individual companies in the competitive environment. en 2009-09-10 Decision Resources, Inc. http://www.the-infoshop.com/study/dr100336-biopharma-qtr.html The first Phase 0 trial results, the first fruits of Japan' s biosimilar pathway, the first straightforward use of the social marketing tool Twitter to advance a drug franchise, the first moves of the EU to regulate third-party mentions of pharmaceuticals, the first encounter with the H1N1 strain of infl uenza. These firsts of the second quarter of 2009 are among the developments that companies in the biopharma sector should consider in the context of their business strategies. This report provides biopharma players with event- and trend-related alerts, explanations, and models to heed. en Biomarker 2009-09-09 Markets and Markets http://www.the-infoshop.com/study/mama99909-biomarkers.html The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions. en Biomaterials 2009-09-09 Markets and Markets http://www.the-infoshop.com/study/mama99910-glob-bio-mtrl.html The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market. en 2009-09-03 Business Insights http://www.the-infoshop.com/study/rb99420-global-bioinformatic.html This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they have. en 2009-09-01 Kalorama Information http://www.the-infoshop.com/study/kl99249-implant-based-dental.html The recession will have an impact on any elective medical procedure, and dental implants (and the resulting bone grafts) are no exception. Since the last edition of Kalorama Information' s Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, economic conditions have changed in US and world markets, but the industry has also changed: mergers, new products, an increase in computer design and trained dentists are driving growth, as is reimbursement. en Biotechnology Equipment 2009-09-01 data information intelligence GmbH http://www.the-infoshop.com/study/dii102233-de-molecu-diagno.html This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. en Biotechnology Equipment 2009-09-01 data information intelligence GmbH http://www.the-infoshop.com/study/dii102234-fr-molecu-diagno.html This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. en Biotechnology Equipment 2009-09-01 data information intelligence GmbH http://www.the-infoshop.com/study/dii102237-uk-molecu-diagno.html This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. en Biotechnology Equipment 2009-09-01 data information intelligence GmbH http://www.the-infoshop.com/study/dii102238-it-44na-test.html This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. en Biotechnology Equipment 2009-09-01 data information intelligence GmbH http://www.the-infoshop.com/study/dii102239-es-molecu-diagno.html This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103096-blood-banking-world.html This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103097-leading-blood-banking.html This report presents extensive analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. en Antibody & Immunity 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103098-blood-typing-grouping.html The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103099-blood-banking-tech.html This report provides a detailed analysis of 13 current and emerging technologies, and their potential market applications. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103100-french-blood-banking.html This report presents a comprehensive analysis of the French blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103101-german-blood-banking.html This report presents a comprehensive analysis of the German blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103102-italian-blood-banking.html This report presents a comprehensive analysis of the Italian blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103103-japanese-blood-bank.html This report presents a comprehensive analysis of the Japanese blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103104-spanish-blood-bank.html This report presents a comprehensive analysis of the Spanish blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103105-uk-blood-banking.html This report presents a comprehensive analysis of the UK blood banking market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103106-us-blood-bank.html This report presents a comprehensive analysis of the US blood banking market. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103118-coagulation-test.html This report provides a worldwide overview of the coagulation testing market, including estimates of facilities performing coagulation tests, as well as test volume and sales forecasts for coagulation reagents and instruments by country. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103119-coagulation-tech.html This report provides a detailed analysis of the current and emerging coagulation technologies and their potential market applications. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103120-coagulation-instr.html This report reviews current instrumentation technologies, and compares features of nearly 50 leading automated and semiautomated analyzers. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103121-coagulation-mkt.html This report presents analyses of major current and emerging suppliers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103122-coagulation-prod.html The report identifies major opportunities for coagulation instrument and consumable suppliers, proposes ideal product models with tentative prices and operating characteristics, and suggests alternative market penetration strategies. en Biotechnology Equipment 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103123-coagulation-test.html The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103124-fr-coagulation.html This report presents a comprehensive analysis of the French coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103125-de-coagulation.html This report presents a comprehensive analysis of the German coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103126-it-coagulation.html This report presents a comprehensive analysis of the Italian coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103127-jp-coagulation.html This report presents a comprehensive analysis of the Japanese coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103128-es-coagulation.html This report presents a comprehensive analysis of the Spanish coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103129-uk-coagulation.html This report presents a comprehensive analysis of the UK coagulation market. en 2009-09-01 Venture Planning Group http://www.the-infoshop.com/study/vpg103130-us-coagulation.html This report presents a comprehensive analysis of the US coagulation market. en Genome-based Drug Discovery 2009-08-31 Insight Pharma Reports http://www.the-infoshop.com/study/cd99267-ion-channel-modulator.html Ion Channel Modulator Pipelines: Targets and Agents in Development provides a comprehensive analysis of the ion channel modulator pipeline, breaking it down by company, ion channel type, and therapeutic indication. en Antibody & Immunity 2009-08-31 Insight Pharma Reports http://www.the-infoshop.com/study/cd99268-monoclonal-antibodies.html Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment presents an analysis for the current state of mAb drug development. It identifies more than 250 therapeutic products now in clinical trials, which are largely concentrated in the areas of cancer, immunological and inflammatory diseases, as well as infectious diseases. en Biomarker 2009-08-21 Decision Resources, Inc. http://www.the-infoshop.com/study/dr98547-uncovering-biomarker.html Despite the robust drug market for immune and infl ammatory diseases and their high prevalence, diagnostics associated with these diseases do not constitute a large marketplace. en 2009-08-18 Datamonitor http://www.the-infoshop.com/study/dc98354-molecular-target-cancer.html Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent expiries, it is unsurprising that the major oncology companies have shifted their focus towards the molecular targeted cancer therapies market. en 2009-08-18 Datamonitor http://www.the-infoshop.com/study/dc99559-cancer-therapies.html Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent expiries, it is unsurprising that the major oncology companies have shifted their focus towards the molecular targeted cancer therapies market. en Gene Therapeutics & RNAi 2009-08-14 Frost & Sullivan http://www.the-infoshop.com/study/fs98072-european-biopharma.html The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. en 2009-08-14 Datamonitor http://www.the-infoshop.com/study/dc98360-prostate-cancer.html Incidence of prostate cancer in the seven major markets will be just over 422,000 in 2009, indicating high patient potential for drug developers to invest in. There are currently 136 agents in development for prostate cancer, two-thirds of which are novel targeted therapies or immunotherapies. Collectively, the nine drugs in late-phase development are forecast to achieve $2,780m in sales by 2018. en Biomarker 2009-08-12 Business Insights http://www.the-infoshop.com/study/rb97740-person-medicine.html 1Over the past decade, several significant advances in targeted therapies have improved the ability to treat certain cancers, the most notable early successes been trastuzumab in breast cancer and imatinib in chronic myelogenous leukemia. Recently, several important breakthroughs have occurred, including the identification of a mechanism of resistance to EGFR monoclonal antibodies in colorectal cancer, which may be followed by further predictive tests leading to a reduction in the use of ineffective therapies. en Genome-based Drug Discovery 2009-08-10 Takeda Pacific http://www.the-infoshop.com/study/tak97415-diagno-drug-rd.html This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-capture arrays for targeted resequencing, array-based molecular diagnostics and related areas. The study reviews microfluidic bioarrays such as for POC diagnostics through credit card-sized devices, for liquid chromatography, or for drug discovery optimization. This study also discusses commercial developments in protein bioarrays and SPR biosensors. en 2009-08-09 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc96286-ap-biotechnology.html According to our new research report, Asia Pacific Biotechnology Market (2008-2012), the Asia-Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012. Currently, the industry is driven by new developing markets like Malaysia and India where developments in the sector are on a full swing. Anticipating the future growth, governments are promoting the industry by making investments and implementing new strategies. en 2009-08-09 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc98391-glob-protein-thera.html This report provides extensive information and rational analysis of the global protein therapeutics market. It includes detailed study of factors fueling growth in the protein therapeutics market to help clients gain deeper insight of the current and future trends in the global protein therapeutics market. The report also provides segment-wise market trends prevailing at regional level to provide an overview of developments taking place in these segments across the world. en Antibody & Immunity 2009-08-06 Visiongain http://www.the-infoshop.com/study/kt100716-monoclonal-antibody.html Monoclonal antibodies achieved total sales of nearly $32bn in 2008 and have grown rapidly to command over 30% of the global biologic drug market. We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new report, Monoclonal Antibody Therapeutics 2009-2024. en 2009-08-04 PMR http://www.the-infoshop.com/study/pmr96356-pl-biotech-innova.html Biotechnological innovations in the pharmaceutical industry in Poland 2009 provides a comprehensive overview of the biotechnology market in Poland. Covering major industry trends and events, it touches on both domestic and international occurrences that have significance to the Polish market. en Gene Therapeutics & RNAi 2009-08-03 BioInformatics, LLC http://www.the-infoshop.com/study/bf91467-epigenetics-market.html In this study, scientists elaborate on processes and techniques they use to do epigenetics research, problems with protocols and antibodies, changes expected in the time/effort devoted to epigenetics research over the next couple of years and the estimated change in spending on chIP-related consumables through 2011. en Genome-based Drug Discovery 2009-08-01 Trimark Publications http://www.the-infoshop.com/study/tk82871-cell-based-assay.html The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications that require sufficient levels of sample throughput, whereby complex cellular events and phenotypes can be studied. Elements of drug performance like toxicity and specificity can be established simultaneously using mixed cell types-primary cells, cell lines, cell subpopulations. HCS seeks to assess the impact of phenotypic and cellular changes that are brought about by gene modification (such as with RNA interference (RNAi) approaches) and/or drug (or compound) treatment. The purpose of this examination by TriMark Publications is to describe the specific segments of the global drug discovery tools market. en Biotechnology Equipment 2009-08-01 Kalorama Information http://www.the-infoshop.com/study/kl96360-dna-seq-equip.html Since the last edition of Kalorama Information' s DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or to simply join the pack. en Biomarker 2009-07-31 Koncept Analytics http://www.the-infoshop.com/study/koan96319-molecular-diagno.html The report titled Molecular Diagnostics Industry: Trends and Opportunities analyzes the molecular diagnostics segment of IVD industry. The study explores the potential business opportunities that exist in the molecular diagnostics industry. Further, factors that are driving the growth of the industry have been assessed. Also, major industry trends have been outlined. The report analyzes the level of competition in the molecular diagnostics industry and also profiles the leading players underlining their sales and business strategies. en Genome-based Drug Discovery 2009-07-31 Insight Pharma Reports http://www.the-infoshop.com/study/cd96403-data-mining-drug.html The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. en 2009-07-31 Millennium Research Group http://www.the-infoshop.com/study/mrg96901-eu-ortho-bio-mtrl.html This market comprises hyaluronic acid viscosupplementation, bone graft substitutes, and knee cartilage repair products sold in Austria, France, Germany, Italy, Spain, and the UK. en 2009-07-23 BCC Research http://www.the-infoshop.com/study/bc95305-biotechnology-research.html The global economic downturn that began in 2008 has slowed growth in nearly all technology sectors, including biotechnology markets. Nonetheless, the high value that biotechnology products can deliver, and the long-term growth potential of the sector will surely result in increased capital input and long-term sustained growth when the global economy recovers. en Genome-based Drug Discovery 2009-07-20 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb94760-microrna-diagno.html This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for the development of MicroRNA Diagnostics and Therapeutics and this Market Report brings together these Emerging Disciplines. This comprehensive report provides a thorough discussion and analysis of the cancer personalized medicine space and from both a technical as well as market-focused perspective. en 2009-07-20 La Merie http://www.the-infoshop.com/study/lmer96354-hdac-inhibitors.html The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. en Gene Therapeutics & RNAi 2009-07-14 Frost & Sullivan http://www.the-infoshop.com/study/fs94578-us-mol-cytogenetic.html This research service provides a strategic analysis of the molecular cytogenetics market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challenges and strategies are covered for the total market overview. en Biotechnology Equipment 2009-07-09 Percepta Associates Inc. http://www.the-infoshop.com/study/pai84695-nucleic-acid.html Nucleic acid amplification is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene expression. The Nucleic Acid Amplification Dashboard was developed from responses to a 21-question survey by 485 scientists predominantly located in North America and Europe. en Personalized Medicine 2009-07-09 BCC Research http://www.the-infoshop.com/study/bc94135-personalized-medi.html Personalized diagnosis and treatment - or personalized medicine - is the most recent trend in the multibillion - dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order to improve the drug development process and also to speed up the approval of new drugs. en Molecular Targeted Therapeutics 2009-07-01 Global Industry Analysts, Inc. http://www.the-infoshop.com/study/go95488-molecule-kinase.html This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. en Genome-based Drug Discovery 2009-07-01 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb99253-microrna-research.html This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Research Market Trends. The focus of this report is to document the technical and commercial trends operative in the microRNA research space with emphasis upon the analysis of microRNAs and microRNA associations with specific physiological and pathological/disease processes. en Gene Therapeutics & RNAi 2009-07-01 PharmaVision & Espicom http://www.the-infoshop.com/study/es2100223-delivering-rnai.html The market for RNAi-based therapeutics is forecast to grow from 2013 onwards, as the first products enter the marketplace, to generate sales in excess of US$2.9 billion by 2020. The first siRNA-based therapeutics will capitalize on the demand to treat viral infections and ocular conditions, and in the longer term companies will be able to target niche areas of high unmet clinical need such as cancer, cardiovascular disease, metabolic disorders, inflammatory and neurological conditions. en 2009-06-30 Business Insights http://www.the-infoshop.com/study/rb92436-biotech-exit.html Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. en Genome-based Drug Discovery 2009-06-30 Insight Pharma Reports http://www.the-infoshop.com/study/cd92441-solving-genome.html Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. en Genome-based Drug Discovery 2009-06-30 Insight Pharma Reports http://www.the-infoshop.com/study/cd92511-pharmacogenomics.html Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. en Genome-based Drug Discovery 2009-06-30 BCC Research http://www.the-infoshop.com/study/bc92659-proteomics.html The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. en Biomarker 2009-06-30 Technical Insights, Inc. http://www.the-infoshop.com/study/ti94585-adv-biomarker.html This research service outlines the key global developments in the field of biomarkers. en 2009-06-23 BCC Research http://www.the-infoshop.com/study/bc90899-synthetic-biology.html The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013. en Gene Therapeutics & RNAi 2009-06-15 Decision Resources, Inc. http://www.the-infoshop.com/study/dr91143-genetic-test.html Progress aptly describes the expanding field of genetic testing. The field is more than finding linkages of genes with diseases: it encompasses technologies that have made it easier to quickly and more efficiently discover genetic markers that predict disease, diagnose disease, and guide prescribing. Applications of genetic tests are evolving as the technologies to refine them are improving - in addition to the typical diagnostic/biopharma client, interest is flourishing among vendors that are targeting consumer health. This combined push is creating strong incentives for select populations and payers to request such tests, which could translate to large payoffs for those driving genetic diagnostic development efforts. en Genome-based Drug Discovery 2009-06-10 Insight Pharma Reports http://www.the-infoshop.com/study/cd90942-bioinformatic-computa.html The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associated only with semiconductor devices. en Biotechnology Equipment 2009-06-09 Percepta Associates Inc. http://www.the-infoshop.com/study/pai84694-nucleic-acid.html Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. en 2009-06-04 Decision Resources, Inc. http://www.the-infoshop.com/study/dr90858-biopharma-quarter.html No Bear Stearns, no Lehman Brothers, no Chrysler, no humiliating hat-in-hand audiences with Congress. The biopharma industry has not seen one of its leaders tumble in the way that the financial and automotive industries have. Certainly, though, many smaller players are succumbing in the international economic meltdown; major players are making moves that are critical to their survival; and the possibility of a federal bailout of the biotech industry has been raised. Clearly, the state of the economy is hastening change in the industry, which will confront a narrowed playing field, greater cost-consciousness, and opportunities to innovate in terms of technologies and business models. en Gene Therapeutics & RNAi 2009-06-01 Trimark Publications http://www.the-infoshop.com/study/tk89489-genetics-bundle.html The Genetics Bundlel includes 8 reports based on the genetic markets. en Genome-based Drug Discovery 2009-06-01 Trimark Publications http://www.the-infoshop.com/study/tk89615-pharmacogenom.html Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall. This TriMark Publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. en Regenerative Medicine 2009-06-01 Trimark Publications http://www.the-infoshop.com/study/tk89848-stem-cell.html The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease. en Antibody & Immunity 2009-06-01 Trimark Publications http://www.the-infoshop.com/study/tk89850-thera-mono-antib.html Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through recombinant DNA technology that has the ability to combine specifically with a target protein that plays a role in a disease process. With this unique ability to specifically target diseased cells while leaving healthy cells unaffected, monoclonal antibodies can serve to diagnose and treat a wide range of medical conditions. Areas such as breast cancer therapy have benefited greatly since the advent of drugs like Herceptin (trastuzumab) that interferes with the HER2/neu receptor. Indeed, the field of therapeutic monoclonal antibodies potentially has far-reaching and paradigm-shifting implications for biology, drug discovery, and medical treatment of disease en Biomaterials 2009-06-01 iData Research Inc. http://www.the-infoshop.com/study/ida97362-dental-bone.html In 2008, the combined U.S. market for dental bone graft substitutes and other biomaterials was valued at just under $200 million. en Antibody & Immunity 2009-05-29 BioInformatics, LLC http://www.the-infoshop.com/study/bf89828-market-for-antibodies.html The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III will help suppliers better understand how antibodies are used and how demand is impacted by scientific application. In addition, segmentation analysis and trend comparisons will allow suppliers to adapt to preferences by type of customer, and to modify product offerings to accurately reflect changes in the antibodies market. This report can be used to assess a supplier' s competitive position and to validate internal market share/size calculations. This information will also help suppliers better understand their strengths and weaknesses as compared to their competitors and gauge their brand' s overall performance in the antibody market. en Genome-based Drug Discovery 2009-05-26 Frost & Sullivan http://www.the-infoshop.com/study/fs89718-euro-theranostics.html This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported. en Genome-based Drug Discovery 2009-05-20 Frost & Sullivan http://www.the-infoshop.com/study/fs89664-euro-lab-on-chip.html This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015. en 2009-05-20 Decision Resources, Inc. http://www.the-infoshop.com/study/dr90281-economic-tsunami.html In 2008, the global financial crisis radically altered the dynamics of the biotech industry; many weaker companies will fail. However, private investment in biotech continued, and pharmaceutical companies invested significant sums in acquiring and partnering with biotech companies offering innovative products and technologies for drug discovery. en Regenerative Medicine 2009-05-15 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc87559-us-stem-cell.html US Stem Cell Market Analysis provides extensive research and thorough analysis of the current industry trends driving the growth of stem cell market in the US. This report highlights the emerging segments in the market alongwith their market potential to serve the country' s population. The report will help the clients to understand the market dynamics and get an insight of the current and the future outlook of stem cells market in the US en Molecular Targeted Therapeutics 2009-05-07 Business Insights http://www.the-infoshop.com/study/rb87079-protein-kinase.html Kinases are a ubiquitous group of enzymes that catalyze the phosphoryl transfer reaction from a phosphate donor (usually ATP) to a receptor substrate, which can be protein, lipid, or a small molecule (e.g. sugar). Phosphorylation of protein substrates is a fundamental and reversible mechanism for regulating protein activity in eukaryotes. en Antibody & Immunity 2009-05-07 Decision Resources, Inc. http://www.the-infoshop.com/study/dr87286-dealmak-industry.html The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral development. en Antibody & Immunity 2009-05-07 Visiongain http://www.the-infoshop.com/study/kt92343-monoclonal-antibodies.html Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapies. The monoclonal antibodies oncology market has been growing at a significant rate and holds high potential for continued growth in both developed and emerging geographical markets. Currently, new technologies are removing some of the drawbacks that monoclonal antibody therapies have experienced. Leading pharma companies are already investing heavily in monoclonal antibody technologies. Monoclonal antibodies with great commercial potential are in the oncology pipeline, as our new report - Monoclonal Antibodies in Cancer Therapy 2009-2024 - also explains. en 2009-05-01 iData Research Inc. http://www.the-infoshop.com/study/ida78469-asia-orthopedic-bio.html In 2008, the combined Asia Pacific Biomaterials market was worth $810.2 million. This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluronic acid viscosupplementation, and bone morphogenic growth factor therapy. en Regenerative Medicine 2009-05-01 Kalorama Information http://www.the-infoshop.com/study/kl85187-cell-culture.html Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. en Genome-based Drug Discovery 2009-05-01 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb94761-epigenetics.html This is the latest and most up-to-date Epigenetics, Cellular Reprogramming, and iPSC Market Analysis Report from Select Biosciences. en Biotechnology Equipment 2009-04-28 Infiniti Research Limited http://www.the-infoshop.com/study/infi86542-biosensors.html This report forecasts the market size of the Medical Biosensors Market over the period 2008-2012. The total market is segmented into various geographic regions, presenting the market size of Medical Biosensors Market in each of these regions. Further, the report provides the market segmentation for the Medical Biosensors Market, by category. It also discusses the market trends in the Medical Biosensors Market, and talks about the applications of Medical Biosensors in the Healthcare sector. The major growth drivers and growth barriers of Medical Biosensors Market are also covered in the report. In addition, the report mentions the medical trade shows and conferences attended by some of the Medical Biosensors Market vendors. The report also profiles some of the Medical Biosensors Market vendors operating in the Healthcare sector. en Personalized Medicine 2009-04-17 Decision Resources, Inc. http://www.the-infoshop.com/study/dr86118-nucleic-acid.html One of the fastest-growing segments of molecular diagnostics is nucleic acid testing (NAT). NAT is central to the life sciences industry, to improved healthcare, and to personalized medicine. Tools based on NAT are used to discover new biomarkers and develop in vitro diagnostics. Companies large and small are recognizing the value of NAT, and both R&D and dealmaking activity is robust. Find out who the players are and how they are vying for commercial success. en 2009-04-15 Frost & Sullivan http://www.the-infoshop.com/study/fs85571-eu-biotech-comp.html This research service aims to profile some of the promising biotech companies in Europe across different countries and segments. en Regenerative Medicine 2009-04-10 Datamonitor http://www.the-infoshop.com/study/dc85285-stem-cell-trans.html Hematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens. Nowadays, it has a range of applications, including the treatment of certain hematologic malignancies. However, further research efforts are required to expand its use and improve patient outcomes. en Regenerative Medicine 2009-04-02 BioInformatics, LLC http://www.the-infoshop.com/study/bf84537-stem-cell-prod.html Capitalizing on New Opportunities for Stem Cell Products provides a roadmap for stem cell product suppliers to help navigate a landscape that is poised for change- and growth. This analysis was designed to guide suppliers in redirecting resources to new areas and markets, and to help refine current offerings by making them more responsive to scientists who are already engaged in stem cell research. en 2009-04-01 iData Research Inc. http://www.the-infoshop.com/study/ida78468-euro-orthopedic-bio.html In 2008, the combined European biomaterial market was worth ?271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Within this report, the various bone grafting materials are examined, including autografted bone, allografts, demineralized bone and synthetic bone substitutes. en 2009-04-01 Kalorama Information http://www.the-infoshop.com/study/kl83670-molecular-diagnostics.html From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama' s leading diagnostic analyst, Shara Rosen. en Personalized Medicine 2009-04-01 Kalorama Information http://www.the-infoshop.com/study/kl84448-pharmacodiagnostics.html Pharmacodiagnostics are considered the pathway to what has been termed personalized medicine, the use of molecular analysis to achieve optimum medical outcomes in the management of a patient' s disease or predisposition to disease. en Genome-based Drug Discovery 2009-04-01 Trimark Publications http://www.the-infoshop.com/study/tk84853-companion-biomarkers.html This TriMark Publications report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. en 2009-03-31 BCC Research http://www.the-infoshop.com/study/bc84304-women-disorder.html This newly updated BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the market for women' s therapeutic and diagnostic products. The geographical scope of this study is U.S. based. en Genome-based Drug Discovery 2009-03-31 Frost & Sullivan http://www.the-infoshop.com/study/fs84728-us-micro-rna.html This research service provides a strategic analysis of the microRNA services market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challenges and strategies are covered for the total market overview. en Regenerative Medicine 2009-03-31 Frost & Sullivan http://www.the-infoshop.com/study/fs86349-us-tissue-repair.html This research service studies the orthopedic soft tissue repair markets in the United States. The market is segmented as cartilage repair and meniscus repair markets. It covers the market from the aspects of the driving forces, restraints and challenges, also providing strategic recommendations. Revenue and procedure analyses are provided in the study for a forecast period of 2008-2015. Market share and competitor structure of the market is also discussed. en Genome-based Drug Discovery 2009-03-31 Technical Insights, Inc. http://www.the-infoshop.com/study/ti95353-innova-biochips.html This research service discusses the assessment of innovations in biochips. en Biomarker 2009-03-27 Decision Resources, Inc. http://www.the-infoshop.com/study/dr84195-omics.html Genomics has paved the way for its cousin, proteomics, to secure its share of the omics hype. Researchers look to proteomics to deliver on the promise to assess the viability of drug targets for monitoring disease progression, optimizing disease management, and diagnosing diseases with more precision. en Personalized Medicine 2009-03-26 Decision Resources, Inc. http://www.the-infoshop.com/study/dr84010-age-p-medicine.html The promise of personalized medicine is having a profound impact on the healthcare industry. It promises to change the way healthcare is delivered and how drugs and diagnostics are developed. Pharma companies are still worried. en Biomaterials 2009-03-26 Millennium Research Group http://www.the-infoshop.com/study/mrg87443-orthopedic-bio.html The US orthopedic biomaterial market, comprising bone graft substitutes, hyaluronic acid viscosupplementation, machined bone interbody devices, knee cartilage repair grafts and devices, and cell concentration systems was valued at nearly $2.5 billion in 2008. en Biomarker 2009-03-24 Research Facts Ltd. http://www.the-infoshop.com/study/rf83893-molecular-diagnostics.html Molecular diagnostics enables the early detection of diseases and conditions, the selection of targeted, individualised treatment options and the monitoring of treatment efficacy. Tests are available for a wide variety of diseases and conditions ranging from cancer to cardiovascular disease to cystic fibrosis. en Regenerative Medicine 2009-03-23 Visiongain http://www.the-infoshop.com/study/kt86436-stem-cells-hype.html Stem cells represent one of the most promising medical breakthroughs of all time, as our new market report explains. Currently, in 2009, the new US administration is lifting some major restrictions on stem cells technologies. en Biotechnology Equipment 2009-03-19 Insight Pharma Reports http://www.the-infoshop.com/study/cd83742-genetic-test.html The current marketplace for direct-to-consumer (DTC) genetic testing is very dynamic and fluid. At least 42 DTC genetic testing companies have been identified to date, and additional market entrants are likely. Firms marketing and selling genetic tests DTC have numerous factors to consider. en Regenerative Medicine 2009-03-10 BioInformant http://www.the-infoshop.com/study/biof83342-stem-cell.html BioInformant' s latest market report, Stem Cell Research Products: Opportunities, Tools & Technologies, published March 2009, is creating quite a buzz in the industry. The report was produced using a detailed end-user survey of research scientists, in which over 400 chemists and biologists from North America, Europe, and Asia completed participated. The findings represent perspectives across a global audience of researchers. en Genome-based Drug Discovery 2009-03-09 Business Insights http://www.the-infoshop.com/study/rb84803-biobanks.html Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based biobanks have been established which monitor the health status of participants over time to assess the natural occurrence and progression of common diseases. en 2009-03-09 Millennium Research Group http://www.the-infoshop.com/study/mrg87433-dental-biomaterial.html This report provides the detailed information about US Markets for Dental Biomaterials 2009. en 2009-03-06 BioInformatics, LLC http://www.the-infoshop.com/study/bf83301-life-s-suppliers.html This report will help life science suppliers weather the financial storm of 2009. Pharmaceutical, biotechnology, academic and government labs are bracing for budget freezes and staff reductions. Use this report to understand how scientists plan to control lab costs, what products will be affected and the degree of concern scientists have about the economic climate. en Molecular Targeted Therapeutics 2009-03-04 Datamonitor http://www.the-infoshop.com/study/dc83987-dc83987-cystic-fibrosis.html With cystic fibrosis patients still dying prematurely and only two products currently approved for the treatment of this disease, the market is wide open for new entrants. Not only will novel symptomatic treatments and re-formulations lead to improved treatment paradigms, truly disease-modifying compounds are in late-stage development and will significantly change the market. en Genome-based Drug Discovery 2009-03-01 Trimark Publications http://www.the-infoshop.com/study/tk82868-bioinformatics.html The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications believes that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth. Each segment is accompanied by analysis and forecasts by product type and application. en Regenerative Medicine 2009-03-01 BioInformant http://www.the-infoshop.com/study/biof82924-mese-stem-cell.html This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. Additionally, this report provides guidance for companies that offer or wish to offer competitive stem cells products to this rapidly growing, well-funded research community. en Regenerative Medicine 2009-03-01 BioInformant http://www.the-infoshop.com/study/biof82926-neuronal-stem.html Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. en Biotechnology Equipment 2009-03-01 Kalorama Information http://www.the-infoshop.com/study/kl83094-liquid-chromato.html The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of components since the 1980s. en Biomaterials 2009-03-01 iData Research Inc. http://www.the-infoshop.com/study/ida83438-us-bone-pins.html The orthopedic bioabsorbable bone pins and screws market includes resorbable shoulder, ACL/PCL, meniscus, and fracture fixation devices. Over the forecast period, unit sales, average selling prices and total market value are estimated to increase steadily. en Biotechnology Equipment 2009-03-01 Research Facts Ltd. http://www.the-infoshop.com/study/rf85467-n-ameri-mol-diag.html Molecular diagnostics enables the early detection of diseases and conditions, the selection of targeted, individualised treatment options and the monitoring of treatment efficacy. Tests are available for a wide variety of diseases and conditions ranging from cancer to cardiovascular disease to cystic fibrosis. Molecular diagnostics is the fastest-growing segment of the in vitro diagnostics industry and it is poised to deliver strong double-digit annual growth over the next several years. It is therefore an attractive segment to be involved in. en Biotechnology Equipment 2009-03-01 Research Facts Ltd. http://www.the-infoshop.com/study/rf85469-cancer-mol-diag.html Molecular diagnostic tests will increasingly be used for cancer screening, diagnosis, staging, therapy selection and relapse monitoring. Molecular diagnostics is the fastest-growing segment of the in vitro diagnostics industry and cancer molecular diagnostics in particular represents a market forecasted to grow at in excess of thirty percent per year. en Antibody & Immunity 2009-02-19 Best Practices, LLC http://www.the-infoshop.com/study/bepr83156-rituxan-case.html This case study reviews the strategy and tactics utilized by Genentech for the Rheumatoid Arthritis (RA) indicated product, Rituxan, to communicate with KOLs regarding a new mechanism of action treatment for moderate-to-severe RA. The company started by using advisory boards early to harvest insights and seed new ideas before turning to communication vehicles such as peer-to-peer discussions and seminars to redefine RA' s existing scientific model for the medical community. The approach created understanding and acceptance for Rituxan' s new mechanisms of action. Executives and managers can use this study to gain insights into the creation of messages that communicate how a product with a new MOA changes a dominate treatment paradigm. en 2009-02-09 BURRILL & COMPANY http://www.the-infoshop.com/study/burr82127-biotech2009.html Biotech 2009-Life Sciences: Navigating the Sea Change is the 23rd edition of this yearly publication. It provides a compass to guide you through the current financial market turmoil. The 400-plus page book contains analysis and perspectives on the performance of the industry in 2008 and projections for 2009 and beyond. The biotech industry has had nearly 40 years of easy access to inexpensive capital. The capital markets have permanently restructured, making access to capital more difficult and expensive to access. en 2009-02-01 Asia Market Information & Development Co. http://www.the-infoshop.com/study/amid81743-cn-biopharma.html China' s demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled. en Regenerative Medicine 2009-02-01 Kalorama Information http://www.the-infoshop.com/study/kl82648-stem-cell.html Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. en Molecular Targeted Therapeutics 2009-02-01 Insight Pharma Reports http://www.the-infoshop.com/study/cd83743-protease-inhibitor.html Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteria, and parasites, which are also potential drug targets. The therapeutic promise of protease inhibitors has been most clearly demonstrated by angiotensin-converting enzyme (ACE) and HIV drugs. en Biomarker 2009-02-01 Global Industry Analysts, Inc. http://www.the-infoshop.com/study/go84763-cardiac-biomarkers.html This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. en Genome-based Drug Discovery 2009-02-01 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb94762-toxicity-screening.html This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market metrics, and thorough bottom-up based market trends obtained via detailed market surveys administered by Select Biosciences to a worldwide industry participant pool. en Molecular Targeted Therapeutics 2009-02-01 Biophoenix Limited http://www.the-infoshop.com/study/biop95662-cancer-diseases.html Apoptosis is regarded as the major mode of cell death in cancer and should therefore be considered as a potential target when developing new antineoplastic drugs. An increasing number of companies are doing so, and we anticipate that this approach will pay substantial dividends, both therapeutically and commercially. en 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82328-antibodie-oncology.html The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic antibodies. Today, there are more than 330 companies plus partners developing more than 450 antibody based oncology drugs in more than 880 developmental projects. en 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82330-apopto-oncology.html Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells. en 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82335-immu-oncology.html Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators in oncology drug development into one source. There are today more than 290 immunotherapy drugs in active development for the treatment of cancer, from early preclinical to marketed drugs. In addition, the accumulated number of ceased drugs over the last three years amount to another 159 drugs. Immunotherapy in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 84 different targets. These targets are further categorized on the CD-ROM by 37 classifications of molecular function and with pathway referals to BioCarta, KEGG and NetPath. Read more below on how the Immunotherapy in Oncology: Drug Pipeline Update is organized. en 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82340-protein-kinase.html Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful drugs are just the top of an emerging line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, there is plenty of room for more competition. en 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82349-tool-protein-kina.html Analytical Tool - Protein Kinase Inhibitors in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available. en Molecular Targeted Therapeutics 2009-01-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg82352-ana-tool-apoptosis.html Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptopic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. en Biomarker 2009-01-17 Decision Resources, Inc. http://www.the-infoshop.com/study/dr79466-personal-medi.html Biomarkers - physical characteristics that are objectively evaluated as indicators of normal biological processes, pathogenic processes, or pharmacological responses to therapeutic intervention - are high-valueadded commodities in drug and diagnostics discovery and development, and biomarker-based strategies are the key to success in personalized medicine. In 2008, these strategies were manifest in a variety of biomarkercentered partnerships that involved pharmaceutical and biotech companies, academic institutions, and government agencies and in several signifi cant M&As that we examine in this report. en Personalized Medicine 2009-01-15 Mintel International Group Ltd, http://www.the-infoshop.com/study/mt79918-customized-health.html Customized health - designing healthcare services based on the unique needs of consumers - is one of the most important trends in the healthcare category, and holds significant opportunities for companies that offer the right products and services. en 2009-01-13 Fuji-Keizai U.S.A., Inc. http://www.the-infoshop.com/study/fuji79703-epigene-healthc.html This report presents information about the quickly emerging worldwide epigenetics market. This important life science market includes key product areas that will have a powerful impact on current and future healthcare. This broad and high-level report takes a business focus and analyzes epigenetics markets such life science tools and technologies, diagnostics and therapeutics. en Regenerative Medicine 2009-01-06 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb79597-stem-cells.html This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects of stem cells being developed for addressing the opportunities in the cardio and vascular disease spaces. en 2009-01-05 BioPharm Reports (Technology and Markets Ltd) http://www.the-infoshop.com/study/bph79892-alzheimer.html This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AƒÀ and tau related markers, a substantial number of other molecules have been identified, that may offer new opportunities. en 2009-01-02 BCC Research http://www.the-infoshop.com/study/bc78812-biologic-imaging.html The study scope includes the biologic imaging reagents that are commercial or likely to be commercialized within the next five years. Fluorescent probes and dyes, imaging nanomaterials (including quantum dots and other nanoparticles), fluorescent proteins; supermolecules; contrast reagents for MRI, x-ray and ultrasound, and imaging radiopharmaceuticals are studied. Both the in-vivo and in-vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2008 through 2013. Technology status and market driving forces are also discussed. BCC examines imaging reagent producers and the industry structure in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biologic imaging reagents in key diagnostics and R&D tools platforms including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biologic imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents are analyzed, and the main companies in these fields are highlighted. en 2009-01-01 Kalorama Information http://www.the-infoshop.com/study/kl79381-molecular-diagno.html The various clinical techniques and trends are discussed from the point of view of their present and potential market impact. Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. en Gene Therapeutics & RNAi 2008-12-31 Frost & Sullivan http://www.the-infoshop.com/study/fs79541-us-microrna.html This research service analyzes the market for microRNA products within the United States. The market was divided into the microRNA microarray, microRNA qRT-PCR, microRNA functional analysis and microRNA services segments. Each segment covers market drivers and restraints, competitive structure, market share analysis and revenue forecasts. The key challenges, strategies, market trends and technology trends are covered for the total market overview. en Regenerative Medicine 2008-12-31 Percepta Associates Inc. http://www.the-infoshop.com/study/pai79678-cell-culture-life.html The growth and propagation of mammalian cells in culture is a routine but critical precursor to the investigation of such fundamental cellular processes as gene expression and protein function and to the development of therapeutics. This Cell Culture Dashboard was developed based upon the aggregated responses to a 22-question survey completed by more than 400 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the research market for cell culture products. en 2008-12-31 Frost & Sullivan http://www.the-infoshop.com/study/fs79861-us-molecu-diag.html This research service analyzes the market for emerging infectious disease molecular diagnostics within the United States. The United States market was divided into the HPV molecular diagnostics and MRSA molecular diagnostics market segments. en 2008-12-31 Frost & Sullivan http://www.the-infoshop.com/study/fs79879-us-cancer-mo-diag.html This research service analyzes the market for Cancer Molecular Diagnostics within the United States. The market was divided into the Breast Cancer Molecular Diagnostics Market, Colorectal Cancer Molecular Diagnostics Market, Prostate Cancer Molecular Diagnostics Market, and Other Cancer Molecular Molecular Diagnostic Market segments. en Biotechnology Equipment 2008-12-31 Frost & Sullivan http://www.the-infoshop.com/study/fs86462-eu-2d-electropho.html This research service gives a detailed analysis of the 2 dimensional electrophoresis market in Europe from 2004-2014. en 2008-12-24 Millennium Research Group http://www.the-infoshop.com/study/mrg80068-euro-dental-bio.html In 2008, the European dental biomaterial market approached $190 million. This value represents the total revenues from the sale of dental bone graft substitutes (BGS), tissue regeneration (TR) materials, and dental membranes. en 2008-12-22 Datamonitor http://www.the-infoshop.com/study/dc79859-biotech-financing.html Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines. en 2008-12-18 Datamonitor http://www.the-infoshop.com/study/dc86708-solid-organ-trans.html The transplant immunosuppressant market has seen considerable growth in recent years, but this is expected to slow down. Two factors combine to cause a decline in the market from 2011, the limited availability of donor organs and patent expiries of several key products. Neither the shift to once-daily formulations nor the launch of novel biologic therapies will prevent the contraction. en Biomarker 2008-12-17 Decision Resources, Inc. http://www.the-infoshop.com/study/dr79017-oncology-diagno.html In efforts to fi nd new ways to transform the drug development paradigm and the clinical management of cancer, scientists are increasingly turning to discovering cancer biomarkers and developing targeted therapies. The infusion of novel methods, technologies, and strategies - through exploring genes, proteins, and pathways - is enriching traditional approaches. Although notable challenges exist, the possibilities are essentially endless: Where will targeted therapies and companion diagnostics in oncology take us? en 2008-12-15 PharmaVision & Espicom http://www.the-infoshop.com/study/es2100221-stem-cell-therapy.html The fact that stem cell therapies are available in these locations and that patients' travel across the globe to receive them illustrates the high unmet medical need associated with some of the targets being investigated. en 2008-12-04 Visiongain http://www.the-infoshop.com/study/kt81661-top10-biotech-co.html The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970' s. The leading healthcare biotechnology company, Amgen, is now amongst the largest pharmaceutical companies in the world, with other healthcare biotech companies catching up. The global biotech drug market was worth over $75bn in 2007, with double-figure growth noticeably higher that that of the overall pharmaceutical market. Our new report - Top-10 Biotech Companies - Market Outlook, 2008-2023 - will help you to understand those developments and their significance. That report provides valuable commercial information on this exciting industry that no healthcare company should ignore. en 2008-12-03 Decision Resources, Inc. http://www.the-infoshop.com/study/dr78376-biomarker-drug.html Predictive safety biomarkers are categorized by their target action - predicting drug toxicity, selecting patients for treatment, or predicting treatment effi cacy. Increasingly, diagnostics developers and pharmaceutical companies are collaborating on biomarker identifi cation and validation. The role of predictive safety biomarkers in the drug development paradigm is essential in today' s cautious and budget-sensitive environment because pharmacogenomic biomarkers are paramount to informing decisions of patient eligibility for drug treatment, potential toxicities, and drug dosages. en 2008-12-02 Frost & Sullivan http://www.the-infoshop.com/study/fs78024-u.s.-biopharmaceutical.html This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis. en Gene Therapeutics & RNAi 2008-12-01 Trimark Publications http://www.the-infoshop.com/study/tk66630-rna-interfere.html This study defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence market size and growth for RNAi testing. The main objectives of this study are to: 1) understand the different sectors of RNAi testing market and to look at a description of the instruments, reagents and supplies marketed by major companies in each segment; 2) obtain a complete understanding of the individual RNAi-testing platforms-from basic principles to clinical applications; 3) discover feasible market opportunities by identifying high-growth applications in different analytical diagnostic areas, with a focus on the biggest and expanding markets; 4) focus on global industry developments and trends through an in-depth analysis of the major world markets for RNAi measurement technology, including growth forecasts; and 5) present market figures related to the current value of RNAi testing, market projections, market share, key players and sector growth rates. en Biotechnology Equipment 2008-12-01 Kalorama Information http://www.the-infoshop.com/study/kl78012-biophotonics-2nd.html Biophotonics describes the use of photonics in biomedical applications. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. en 2008-12-01 Insight Pharma Reports http://www.the-infoshop.com/study/cd79548-biomedical-imaging.html Molecular imaging has become an increasingly indispensable tool in life sciences basic research, in translational medicine, and in routine medical diagnostics. en 2008-11-30 Datamonitor http://www.the-infoshop.com/study/dc79424-biotechnology.html Datamonitor' s Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. en Biotechnology Equipment 2008-11-28 Percepta Associates Inc. http://www.the-infoshop.com/study/pai78477-nucleic-acid.html The separation of nucleic acids is a necessary precursor to a wide range of life science research and diagnostic techniques. Familiar methods such as cloning/subcloning and Southern and Northern blotting frequently rely on the electrophoretic separation of nucleic acid fragments generated by amplification or restriction digestion. Recently emerging methods such as gene silencing and miRNA analyses often hinge on the separation and sizing of short polynucleotides isolated from cell or tissue samples or synthesized in vitro. For some techniques, such as mutation detection or STR analysis, resolution in the range of a few bases may be required. For other methods, like standard cloning or Southern blotting, a resolution in the tens to hundreds of bases may suffice. en 2008-11-25 Insight Pharma Reports http://www.the-infoshop.com/study/cd77711-stem-cells.html Stem cell science is on the precipice of becoming big business. These enigmatic cells lie at the heart of a fledgling technology with great clinical promise. Stem Cells Come of Age analyzes the current state of stem cell science and technology, and explores some of the non-scientific issues that are part of the emerging, complex, stem cell picture. We begin by tracing the experiments that set the stage for today' s stem cell technology, as well as examining the state of stemness and factors outside the genome that affect cell fate. Human embryonic stem (ES) and induced pluripotent stem (iPS) cells are contrasted - while each can become any cell type of the body (i.e., are pluripotent), each has its own niche. en Personalized Medicine 2008-11-24 Decision Resources, Inc. http://www.the-infoshop.com/study/dr77629-person-medicine.html The pharmaceutical industry has long criticized the slow uptake of new medicines in the United Kingdom. Beginning January 1, 2009, the U.K. government plans to implement measures to accelerate and widen access to innovative drugs. However, the pharmaceutical industry will be expected to adapt to a more fl exible pricing environment. In this report, we analyze the potential impact of the changes unveiled in November 2008. en Biomarker 2008-11-19 Datamonitor http://www.the-infoshop.com/study/dc81159-molecular-diagnostic.html This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests which are positioned in this exciting area of diagnostics. en Genome-based Drug Discovery 2008-11-07 The Freedonia Group http://www.the-infoshop.com/study/fd76258-biochips.html The US market for biochip products and services will increase 9.9 percent per year to $2.5 billion in 2012. Microarrays will sustain the largest portion of product demand based on their consumable nature and expanding applications in drug discovery, life science research, and clinical and forensic testing. DNA chips will continue to lead microarray sales, spurred by widening use in the identification and testing of potential new therapies and diagnostic targets. However, laboratory and protein microarrays will provide faster growth opportunities as the focus of drug discovery and life science research activities shifts from genomics to proteomics. en Gene Therapeutics & RNAi 2008-11-01 Kalorama Information http://www.the-infoshop.com/study/kl76136-genetic-tech.html Genetic Technology is one of the closest-watched areas in healthcare and in the past two years Kalorama Information has published major studies on different aspects of this market. en Genome-based Drug Discovery 2008-10-31 Percepta Associates Inc. http://www.the-infoshop.com/study/pai78486-microrna.html Percepta' s MicroRNA Analysis In North America: A Market Research Report For Life Science Tool Providers takes a close look at the endogenous miRNA research market in the United States and Canada. This report was developed through a combination of primary market research of active miRNA researchers collected in interviews and online questionnaires as well as secondary market research on the suppliers, technologies, and commercial products. This Trends & Opportunities in Early Growth Markets report is designed to provide research tool providers valuable insights into the current miRNA research market and the technologies driving it. en 2008-10-30 BCC Research http://www.the-infoshop.com/study/bc63252-tissue-transp.html This report offers forecasts by product segment from 2008 through 2013, including supporting analyses for projections. Product segments covered consist of solid organs (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation market (e.g., bone, skin, cornea, heart valves), along with the pharmaceuticals that accompany each market. Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells, and altered cancer cells. The arrangement of this report offers an overview of the organ and tissue transplantation market accompanied by analyses and forecasts for each product type and application. en Genome-based Drug Discovery 2008-10-28 Decision Resources, Inc. http://www.the-infoshop.com/study/dr76010-toxicity-prediction.html Drug toxicity is a major cause of costly late-stage development failures and devastating market withdrawals. en Genome-based Drug Discovery 2008-10-27 Datamonitor http://www.the-infoshop.com/study/dc76542-rna-therapy.html RNA therapies have been in development for a number of years, but are yet to achieve any notable commercial success. Improvements have been made following initial attempts and the technology may finally be coming to fruition. en 2008-10-24 Millennium Research Group http://www.the-infoshop.com/study/mrg79702-soft-tissue.html The European market for soft tissue repair devices - comprising vaginal slings, inguinal hernia repair, ventral hernia repair, pelvic floor reconstruction (PFR), staple line reinforcement (SLR), and dural repair devices in France, Germany, Italy, and the UK - was valued at more than $240 million in 2008 . en Biotechnology Equipment 2008-10-14 Frost & Sullivan http://www.the-infoshop.com/study/fs75389-euro-immunoassay.html This research service analyses the market scenario for immunoassays in laboratory and POC setting for major seven European countries. It analyses the market trends, market landscape,competitive strategies along with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these markets to obtain best results in the European market. en 2008-10-13 Business Insights http://www.the-infoshop.com/study/rb75199-biotech-ma.html M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As between biotech companies are also growing in number, stimulated by the drive to strengthen product portfolios and expand participation in the growing global biotech market. Such deal activity is expected to become an increasingly prominent feature in the biotech sector over the next few years.